Bottom line
IBBQ vs SHPAX: the short answer
IBBQ (Invesco Nasdaq Biotechnology ETF) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 24% of their top holdings (by weight) are shared.
But IBBQ is far broader, holding 261 positions to 29 for SHPAX, so beyond the top names it adds exposure SHPAX doesn't have.
IBBQ is cheaper at 0.19% vs 3% — a difference of $281 a year per $10,000 invested.
Over one year, IBBQ returned −0.6% vs −5.5% for SHPAX.
SHPAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
IBBQ vs SHPAX side by side
| IBBQ | SHPAX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Invesco | Saratoga Advantage |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.19% | 3% |
| Annual cost per $10k | $19 | $300 |
| 10-yr cost on $10k (prospectus) | $242 | $3,702 |
| Max front load | None | 5.75% |
| 12b-1 fee | — | — |
| 1-yr return | −0.6% | −5.5% |
| 5-yr return (annualized) | — | +3.1% |
| 10-yr return (annualized) | — | +4.1% |
| Best quarter | +12.0% | +15.0% |
| Worst quarter | −11.7% | −13.0% |
| Net assets (fund) | $67.4M | $10.5M |
| Number of holdings | 261 | 29 |
| Portfolio turnover | 17% | 22% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IBBQ | SHPAX | Difference |
|---|---|---|---|
| 2024 | −0.6% | +0.3% | −0.9% |
| 2023 | +4.5% | −0.4% | +4.9% |
| 2022 | −10.2% | +2.0% | −12.3% |
Source: Fund prospectus bar charts
Holdings overlap
8 of IBBQ's top 25 holdings also appear in SHPAX's top 25.
| Holding | IBBQ | SHPAX |
|---|---|---|
| Gilead Sciences, Inc. | 7.39% | 3.94% |
| Vertex Pharmaceuticals Inc. | 7.38% | 3.36% |
| Amgen Inc. | 7.10% | 5.04% |
| Regeneron Pharmaceuticals, Inc. | 5.08% | 3.93% |
| United Therapeutics Corp. | 1.94% | 6.17% |
| Incyte Corp. | 1.53% | 2.89% |
| Jazz Pharmaceuticals PLC | 1.16% | 6.19% |
| Exelixis, Inc. | 1.04% | 4.55% |
Source: SEC Form N-PORT
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
SHPAX top 10
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Amgen Inc — 5.04%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Gilead Sciences Inc — 3.94%
FAQ
What is the difference between IBBQ and SHPAX?
Which is cheaper, IBBQ or SHPAX?
Should I own both IBBQ and SHPAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.